BioAgilytix Marks 14th Appearance on Triangle Business Journal’s Fast 50 List

Company ranks No. 21 in 2026 following continued investments in scientific expertise, technology, and global bioanalytical capabilities

DURHAM, N.C. — November 12, 2026 — BioAgilytix, a leading global bioanalytical laboratory, has ranked No. 21 on Triangle Business Journal’s 2026 Fast 50 list. This marks the company’s 14th appearance on the annual list recognizing the 50 fastest-growing privately held companies in the Triangle region. 

BioAgilytix’s continued recognition reflects more than business growth. It represents the company’s ongoing investment in the scientific expertise, technology and infrastructure required to help pharmaceutical and biotechnology companies navigate increasingly complex drug development programs. 

“As the science behind new therapies becomes more complex, sponsors need bioanalytical partners that can bring together scientific depth, dependable data, and an understanding of the decisions that data will support,” said Davide Molho, CEO of BioAgilytix. “Our continued growth reflects the trust our clients place in our team and the commitment of our employees to delivering high-quality science.” 

Headquartered in Durham, BioAgilytix has grown from its roots in the Research Triangle into a global organization supporting drug development programs across the United States, Europe, and Australia. The company works alongside pharmaceutical and biotechnology teams from early development through late-phase and commercial programs, providing pharmacokinetic, immunogenicity, biomarker, cell-based assay, LC/MS and chemistry, manufacturing and controls analytical services. 

BioAgilytix continues to expand its capabilities in response to the evolving needs of drug developers. Recent investments have strengthened the company’s support for complex and emerging modalities, expanding its LC/MS and GMP analytical capabilities and advanced the use of automation and digital tools across its global laboratory network. These investments help customers generate consistent, high-quality bioanalytical data while keeping programs aligned with study timelines and regulatory expectations. 

The company’s growth has also been shaped by its long-standing presence in North Carolina’s Research Triangle, one of the country’s leading life sciences communities. BioAgilytix’s Durham headquarters and Morrisville laboratories bring together scientific, operational, and corporate expertise while supporting programs for customers around the world.

About BioAgilytix 

BioAgilytix is a global bioanalytical laboratory partner supporting pharmaceutical and biotechnology companies throughout drug development. With laboratories in North America, Europe and Australia, BioAgilytix provides scientific and operational expertise across pharmacokinetics, immunogenicity, biomarkers, GMP testing and analytical services for complex clinical development programs. Over 1,100 employees are supporting projects from pre-clinical to post marketing.

Media Contact 

Noelle Brawner 
Communications Manager 
BioAgilytix Labs, LLC 
Noelle.brawner@bioagilytix.com